KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

PRESS RELEASE: Spirit acquires leading medical wearable technology developer Aseptika

Spirit INT (Leicester, UK), the parent company of refreshing British healthcare provider Spirit Healthcare (www.spirit-healthcare.co.uk), is further expanding its offer to patients and healthcare professionals through the acquisition of healthcare technology developer Aseptika, a pioneer in the medical wearable and self-care technology sectors.

Bringing Aseptika’s Activ8rlives (www.activ8rlives.com) range of self-monitoring solutions into the Spirit stable alongside its award-winning cloud-based technology CliniTouch Vie, the rapidly growing firm is on a mission to help all patients with long term conditions. From patients who have been recently diagnosed with respiratory problems to those with more complex needs such as Chronic Obstructive Pulmonary Disease (COPD) or Cystic Fibrosis, this extended portfolio will support patients as their healthcare requirements change over time.

Spirit’s CEO Chris Barker said: “At Spirit, we believe that we can offer patients greater control over their own health by rethinking the way that care is delivered and Aseptika shares this vision. The Aseptika team has exceptional experience developing pioneering technology and we’re looking to grow this capability at their Cambridgeshire hub. With these skills, Spirit will be able to accelerate its programme of innovation. We’re innovating and growing fast so we can empower more patients across the UK. This significant acquisition is the second that we’ve made and we’re certainly on the hunt for more acquisition opportunities in the near future.”

Aseptika founder Kevin Auton commented: “We are delighted to be joining the highly successful Spirit group of companies in delivering the new technologies, solutions and services needed to support the growing healthcare needs of the UK. Spirit exemplifies the drive and innovation of the SME sector in delivering the technologies and services our NHS will need in the coming months and years as it accelerates towards digital delivery of healthcare to make its finite resources go further.

“Both companies have been extensively supported through the Small Business Research Initiative for Healthcare (SBRI Healthcare) and Innovate UK programmes. We look forward to bringing the wearable medical monitor BuddyWOTCHTM and the patented home-use test to detect bacterial chest infections to the market to support patients with severe respiratory conditions. Spirit’s ability to build successful partnerships with NHS organisations are a vital route-to-market for the Activ8rlives brand alongside the clear synergies with the Clinitouch VieTM platform to support all levels of disease condition from simple consumer Apps to full telehealth monitoring with Spirits’ 24/7 customer and patient support centre. The benefits of this powerful combination are already evident.”

Barker added: “The Spirit and Aseptika teams have already been collaborating together to develop a cutting edge mobile technology to improve management of type 1 diabetes in a research project in Scotland as part of an SBRI competition so we are excited to explore the future potential of our partnership.”

Karen Livingstone, National Director of SBRI Healthcare and Director of Eastern Academic Health Science Network, commenting on the acquisition said: “I am particularly pleased to see that Aseptika – an SBRI Healthcare backed company – has found a British-based company to partner with.  We know the health market place can be challenging for small companies so it is great that two have combined forces, with the UK economy benefiting from the growth in jobs and revenues.”